Buradasınız

Anasayfa » Content

KOAH ve UYKU BOZUKLUKLARI

COPD AND SLEEP DISORDERS

Journal Name:

  • Uluslararası Hakemli Akademik Spor Sağlık ve Tıp Bilimleri Dergisi

Publication Year:

  • 2012

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Chronic Obstructive Pulmonary Disease (COPD) is commonly seen and has the third range amongst the causes of death. COPD is a chronic and progressive disease and an important cause of morbidity and mortality. It has begun to be seen in equal percentages amongst man and women due to the increase in smoking habit in women. In about half of the patients having COPD, sleep problems are observed and causes impairment in quality of life. Affects of sleep on COPD can not be tolerated as in healthy people and causes more dangerous results. When accompanied by obstructive sleep apnea syndrome (OSAS) prognosis is vorsens rapidly and death comes earlier. In this paper COPD and sleep problems are reviewed.
Bookmark/Search this post with
Abstract (Original Language): 
Kronik obstrüktif akciğer hastalığı (KOAH) Dünya’da sık görülmekte ve ölüm nedenleri arasında üçüncü sırada yer almaktadır. KOAH kronik, ilerleyici bir hastalık olup önemli mortalite ve mobiditeye neden olmaktadır. Son yıllarda kadınlar arasında sigara içiminin artmasına bağlı olarak her iki cinste de eşit oranlarda görülmeye başlanmıştır. Hastalığın seyirinde hastaların yaklaşık yarısında uyku problemleri izlenmekte ve yaşam kalitesinde bozulmalara neden olduğu bilinmektedir. Uykunun KOAH üzerine olan etkileri normal insanlarda olduğu gibi iyi tolere edilememekte ve daha tehlikeli sonuçlara neden olmaktadır. Beraberinde obstrüktif uyku apne sendromu (OSAS) olduğunda prognoz daha hızlı kötüleşmekte ve ölüm daha erken olmaktadır. Bu yazıda KOAH ve uyku problemleri gözden geçirilmiştir.
FULL TEXT (PDF): 
PDF icon arastrmx_25024_2_pp_70-76.pdf
  • 3
70-76
  • Turkish

REFERENCES

References: 

AGUSTİ, A.(2007), Systemic effects of
chronic obstructive pulmonary
disease; what we know and what
we don’t know (but should). Proc
Am Thorac Soc. 4(7): pp.522-525.
ALGHANİM, N., COMONDORE, V.R.,
FLEETHAM, J., MARRA, C.A.,
AYAS, N.T. (2008), The economic
impact of obstructive sleep apnea.
Lung 186(1):pp.7-12.
BARNES, P.J., CELLİ, B.R. (2009),
Systemic manifestations and
comorbidities of COPD. Eur
Respir J 33(5): pp.1165-1185.
CELLİ, B.R., MAC NEE ,W., AGUSTİ,
A., ANZUETO, A., BERG, B.,
BUİST, A.S., CALVERLEY,
P.M.A., CHAVANNES, N.,
DİLLARD, T., FAHY, B. (2004),
Standarts fort the diagnosis and
treatment of patients whit COPD: a
summary of the ATS/ERS position
paper. Eur Respir J 23:pp.932-946.
CHAOUAT, A., WEİTZENBLUM, E.,
KRİEGER, J., IFOUNDZA, T.,
OSWALD, M., KESSLER, R.
(1995), Association of chronic
obstructive pulmonary disease and
sleep apnea syndrome. Am J Respir
Crit Care Med 151:pp.82-86.
CORMİCK,W., OLSON, L.G.,
HENSLEY, M.J., SAUNDERS,
N.A. (1968), Nocturnal hypoxaemia
and quality of sleep in patients whit
chronic obstructive lung disease.
Thorax 41(11):pp.846-854.
DOUGLAS, N.J., WHİTE, D.P.,
PİCKETT, C.K., WEİL, J.V.,
ZWİLLİCH, C.W. (1982),
Respiration during sleep in normal
man. Thorax 37(11):pp.840-844.
HARDİNG, S.M. (2000), Complications
and consequences of obstructive
sleep apnea. Curr Opin Pulm Med
6(6):pp.485-489.
JEMAL, A., WARD, E., HAO, Y., THUN,
M. (2005), Trends in the leading
causes of death in the United States,
1970-2002. JAMA
294(10):pp.1255-1259.
KİM ,V., BENDİTT, J.O., WİSE, R.A.,
SHARAFKHANEH, A. (2008),
Oxygen therapy in chronic
obstructive pulmonary disease.
Proc Am Thorac Soc 5:pp.513-518.
ULUSLARARASI HAKEMLİ AKADEMİK SPOR SAĞLIK ve TIP BİLİMLER DERGİSİ
Nisan-Mayıs-Haziran 2012 Sayısı Sayı: 3 / Cilt: 2 Spring April- May- June 2012 Volume:03 Issue:02 Jel Kodu: JEL I
www.sstbdergisi.com
75
KİNSMAN, R.A., YAROUSH, R.A.,
FERNANDEZ, E., DİRKS, J.F.,
SCHOCKET, M., FUKUHARA, J.
(1983), Symptoms and experiences
in chronic bronchitis and
emphysema Chest 83(5):pp.755-
761.
KLİNK, M.E., DODGE,R., QUAN, S.F.
(1994), The relation of sleep
complaints to respiratory symptoms
in a general population. Chest
105(1),pp.151-154.
KRACHMAN, S.L., CHATİLA, W.,
MARTİN, U.J., NUGENT, T.,
CROCETTİ, J., GAUGHAN, J.
(2005), Effects of lung volume
reduction surgery on sleep quality
and nocturnal gas exchange in
patients with severe emphysema.
Chest 128(5):pp.3221-3228.
LEE, R., MCNİCHOLAS, W.T. (2011),
Obstructive sleep apnea in chronic
obstructive pulmonary disease
patients. Curr Opin Pulm Med
17:pp.79-83.
MANNİNO, D.M., BUİST, A.S. (2007),
Global burden of COPD: risk
factors, prevalence, and future
trends. Lancet 370 (9589): pp.741-
750.
MARİN, J.M., SORİANO, J.B.,
CARRİZO, S.J., BOLDOVA, A.,
CELLİ, B.R. (2010), Outcomes in
patients whit chronic obstructive
pulmonary disease and obstructive
sleep apnea: The overlap
syndrome. Am J Respir Crit Care
Med 182:pp.325-331.
MCNİCHOLAS, W.T.(2000), Impact of
sleep in COPD. Chest 117:pp.48-
53.
MCNİCHOLAS, W.T., CALVERLEY,
P.M., LEE, A., EDWARDS, J.C.
(2004), Long-acting inhaled
anticholinergic therapy improves
sleeping oxygen saturation in
COPD. Eur Respir J 23:pp.825-
831.
MCNİCHOLAS, W.T. (2009), Chronic
obstructive pulmonary disease and
obstructive sleep apnea: Overlaps
in pathophysiology, systemic
inflammation, and cardiovascular
disease. Am J Respir Crit Care Med
180:pp.692-700.
MULLOY, E., MCNİCHOLAS, W.T.
(1993), Theophylline improves gas
exhance during rest, exercise, and
sleep in severe chronic obstructive
pulmonary disease. Am Rev Respir
Dis 148:pp.1030-1036.
MURRAY, C.J., LOPEZ, A.D. (1997),
Alternative projections of mortality
and disability by cause 1990-2020:
Global Burden of Disease Study.
Lancet 349:pp.1498-1504.
PİERCE, A.K., JARRETT, C.E.,
WERKLE, G .J.R., MİLLER, W.F.
(1966), Respiratory function during
sleep in patients with chronic
obstructive lung disease. J Clin
Invest 45(5):pp.631-636.
RABE, K.F., HURD, S., ANZUETO, A.,
BARNES, P.J., BUİST, S.A.,
CALVERLEY, P. (2007),Global
strategy fort the diagnosis,
management, and prevention of
ULUSLARARASI HAKEMLİ AKADEMİK SPOR SAĞLIK ve TIP BİLİMLER DERGİSİ
Nisan-Mayıs-Haziran 2012 Sayısı Sayı: 3 / Cilt: 2 Spring April- May- June 2012 Volume:03 Issue:02 Jel Kodu: JEL I
www.sstbdergisi.com
76
chronic obstructive pulmonary
disease: GOLD executive
summary. Am J Respir Crit Care
Med, 176(6):pp.532-555.
RYAN, S., DOHERTY, L.S., ROCK, C.,
NOLAN, G.M., MCNİCHOLAS,
W.T. (2010), Effects of salmeterol
on sleeping oxygen saturation in
chronic obstructive pulmonary
disease. Respiration, 79: pp.475-
481.
SİN, D.D., MAN, S.F. (2005), Chronic
obstructive pulmonary disease as a
risk factor for cardiovascular
morbidity and mortality. Proc Am
Thorac Soc. 2(1): pp.8-11.
TRASK ,C.H., CREE, E.M. (1962),
Oximeter studies on patients whit
chronic obstructive emphysema,
awake and during sleep. N Engl J
Med 266:pp.639-642.
WEİTZENBLUM, E. (2004), Chaouat A:
Sleep and chronic obstructive
pulmonary disease. Sleep Med Rev
8:pp.281-294.
YOUNG, T., PALTA, M., DEMPSEY, J.,
SKATRUD, J., WEBWR, S.,
BADRE, S. (1993), The occurrence
of sleep-disordered breathing
among middle-aged adults. N Engl
J Med 328(17):pp.1230-1235.

Thank you for copying data from http://www.arastirmax.com